Skip to main content

Table 3 Reported comorbidities in individuals with PMS in our cohort as compared to the literature

From: A Brazilian cohort of individuals with Phelan-McDermid syndrome: genotype-phenotype correlation and identification of an atypical case

Comorbidity

N

Total

Present study

Literature frequencya

Hypotonia

28

33

85%

29–100%

Increased pain tolerance

24

30

80%

10–88%

Recurring upper respiratory tract infections

20

33

61%

8–53%

Chewing difficulties

19

33

58%

50%b

Gastroesophageal reflux

17

30

57%

> 25–44%

Constipation and/or diarrhea

14

33

42%

38–41%

Sleep disturbance

13

33

39%

41–46%

Renal abnormalities

10

33

30%

17–38%

Seizures (febrile and/or non-febrile)

9

34

26%

14–41%

Precocious or delayed puberty

4

28

14%

0–12%

Lymphedema

4

30

13%

22–29%

Cardiac abnormalities

2

34

6%

3–25%

Hearing loss

1

34

3%

NAc

  1. aFrequencies based on the literature review available [15]
  2. bFrequency available in the analysis of PMS individuals carrying SHANK3 point mutations [16]
  3. cAlthough the frequency of this comorbidity was not considered in this study, the literature describes some cases of PMS individuals presenting hearing loss [17, 18]